Securities code: 000710 securities abbreviation: Berry Genomics Co.Ltd(000710) Announcement No.: 2022-002 Berry Genomics Co.Ltd(000710)
On the transfer of part of the company’s shares by the controlling shareholders and their persons acting in concert
Announcement on completion of transfer
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Berry Genomics Co.Ltd(000710) (hereinafter referred to as “the company”) has received the notice from Mr. Gao Yang, the controlling shareholder and actual controller of the company, and Ms. Hou Ying, the person acting in concert, that the transfer of some shares of the company has been completed in China Securities Depository and Clearing Co., Ltd. recently. The details are as follows:
1、 Overview of agreement transfer
Mr. Gao Yang, the controlling shareholder of the company, and Ms. Hou Ying, the person acting in concert (“Transferor”) signed the share transfer agreement with Wang Tianyi (“Transferee”) and Guosen Securities Co.Ltd(002736) (“pledgee”) on December 22, 2021, Mr. Gao Yang and Ms. Hou Ying agree to transfer 9300000 shares of the company’s non tradable shares (accounting for about 2.6226% of the company’s total share capital) to the transferee at a transfer price of 14.45 yuan / share and a transfer price of 134385000 yuan (hereinafter referred to as “this transfer”), and the proceeds will be used to repay the principal of liabilities owed to the Pledgee under the stock pledge financing agreement, To reduce the risk of stock pledge. The transfer complies with the Interim Rules for the handling of negotiated transfer of tradable shares of listed companies, the notice on matters related to the disposal of breach of stock pledge repurchase transaction through negotiated transfer, and the guidelines for the handling of negotiated transfer of shares of listed companies of Shenzhen Stock Exchange. For details, see the suggestive announcement on the transfer of some shares of the company by agreement between the controlling shareholders and their concerted actors (Announcement No.: 2021-078) disclosed by the company on December 24, 2021 Supplementary announcement to the suggestive announcement on the transfer of some shares of the company by agreement between the controlling shareholders and their persons acting in concert (Announcement No.: 2021-080) disclosed on December 29, 2021.
2、 Progress of agreement transfer
Before and after the transfer, the shares held by the transferor and the transferee are as follows:
The name of the transferred shareholder: shareholding before the transfer; shareholding after the transfer
The proportion of the number of shares (shares) in the total share capital (shares) in the total share capital (shares) in the total share capital
Transferor Gao Yang 4681057213.2007% 65000001.8330% 4031057211.3677% Hou Ying 261556617.3760% 28000000.7896% 233556616.5864%
-Total 7296623320.5767% 93000002.6226% 6366623317.9541%
Transferee Wang Tianyi – 93000002.6226%
Note: the above data are the data contained in the register of fixed term holders issued by China Securities Depository and Clearing Co., Ltd.
3、 Impact of agreement transfer
The completion of this transfer will help to reduce the amount of their own debts and the proportion of stock pledge of the company’s controlling shareholders, actual controllers and persons acting in concert. The completion of this transfer has not led to the change of the company’s controlling shareholder and actual controller, has not had a significant adverse impact on the company’s governance structure and sustainable production and operation, and has not damaged the interests of the company and all shareholders.
Mr. Gao Yang and Ms. Hou Ying have not violated the securities law, the measures for the administration of the acquisition of listed companies, the detailed rules for the implementation of share reduction by shareholders, directors, supervisors and senior managers of Listed Companies in Shenzhen Stock Exchange, relevant commitments, departmental rules, normative documents and other relevant provisions. The company will continue to pay attention to their Shanghai Topcare Medical Services Co.Ltd(600532) changes, And will fulfill the obligation of information disclosure in time. Please pay attention to the investment risks. 4、 Documents for future reference
1. Confirmation of securities transfer registration
2. Daily shareholding change details of directors, supervisors and senior managers of China Securities Depository and Clearing Co., Ltd
It is hereby announced.
Berry Genomics Co.Ltd(000710) board of directors January 5, 2022
